Protalix BioTherapeutics, Inc. (DE) financial statements, including revenue, expenses, profit, and loss
The total revenue of PLX for the last quarter is 3.75 M USD, and it's 64.26% lower compared to the previous quarter. The net income of Q1 24 is -4.59 M USD.